Notch is a highly conserved signaling pathway that regulates cell fate decisions in a variety of processes, including embryonic and adult hematopoiesis.
1,2 Notch proteins and their ligands are transmembrane proteins and, upon ligand binding, the Notch intracellular domain (NICD) is released from the membrane by two consecutive proteolytic cleavage events and translocates to the nucleus. In the nucleus, NICD heterodimerizes with the transcriptional repressor CSL/RBPJK and converts it into a transcriptional activator. NICD/RBPJK target genes include those encoding basic helix-loop-helix transcription factors of the Hes and Hey families. 1 Truncated versions of Notch containing only the NICD result in constitutive activation of the pathway. [3] [4] [5] Milner et al. 6 demonstrated that Notch1 is expressed on human CD34
þ bone marrow (BM) hematopoietic progenitor cells. Some years before, the human NOTCH1 gene was found to be disrupted by the chromosomal translocation t(7;9)(q34;q34.3), which yields truncated activated NOTCH1 (TAN-1) transcripts and results in T-cell acute lymphoblastic leukemia (T-ALL). 7 Indeed, more than 50% of T-ALL patients carry mutations leading to constitutive activation of NOTCH1 in T cell. 8 It is now well known that NOTCH1 activation has critical roles at multiple stages of T-cell development. 2 Notch signaling elements are expressed during embryonic and adult hematopoiesis. [9] [10] [11] During embryogenesis, hematopoiesis takes place in two different sites, the yolk sac (YS) and the para-aortic splanchnopleura region (P-Sp). [12] [13] [14] Primitive hematopoiesis begins in the mouse at E7.0-7.5 in the YS blood islands as a transient wave that involves the production of primitive nucleated erythrocytes and certain myeloid progenitor cells. 15 Adult-like definitive hematopoietic cells comprising erythrocytes, macrophages and granulocytes are produced in the YS at E8.25 from transient multipotent progenitors that lack long-term reconstitution potential. 16 At E9.5-10, the intraembryonic P-Sp develops into the aorta-gonads-mesonephros (AGM) region and produces hematopoietic stem cells (HSCs) with long-term reconstitution potential that give rise to all cells of the adult hematopoietic system. These intraembryonic HSCs appear in a cell-autonomous manner as cell clusters in the floor of the dorsal aorta and the vitelline and umbilical arteries. [17] [18] [19] [20] HSCs first generate committed, transit-amplifying progenitors that then differentiate into hematopoietic lineage-restricted progenitor cells. 21 HSCs and progenitor cells migrate to colonize the fetal liver, the spleen, the thymus and finally the BM, which is the main hematopoietic organ during adult life. 21 Normal hematopoiesis is the result of a highly regulated balance between self-renewal, proliferation and differentiation of stem and progenitor cells. Numerous reports based on in vitro and in vivo experiments strongly support a role for Notch in the self-renewal of hematopoietic stem and progenitor cells, and alterations to the Notch pathway disrupt hematopoietic differentiation. [22] [23] [24] [25] Targeted inactivation of the Notch signaling components Notch1, RPBJk, Jag1 and Mib1 showed that Notch is essential for definitive hematopoiesis in the intraembryonic P-Sp/AGM region. 26, 27 The tyrosine kinase receptor-2 (Tie2) is expressed on vascular endothelium and on HSCs, and Tie2 þ cells contain hemangioblasts able to differentiate into hematopoietic and endothelial lineages. 28 Since both Tie2 and Notch1 intracellular domain (N1ICD) proteins have similar expression patterns very early in the YS blood island, 29, 30 we have used the Tie2-Cre driver line 31 to overexpress Notch1 (N1ICD-EGFP (enhanced green fluorescence protein)). 32 In this report, we show that constitutive Notch1 activation in Tie2 þ cells impairs definitive hematopoiesis in the E9.5 embryo and produces severe alterations in YS transient definitive and primitive hematopoiesis. These results demonstrate that Notch signaling has an important function in YS-derived hematopoiesis by balancing the dynamics of proliferation and differentiation of lineagerestricted intermediate progenitors.
Results

Constitutive N1ICD expression in Tie2
þ progenitors impairs definitive intraembryonic hematopoiesis. To study the consequences of Notch1 gain-of-function in hematopoiesis, we used the conditional N1ICD transgenic line R26N1ICD, which upon Cre activation expresses the N1ICD (amino acids 1749-2293) and nuclear-localized enhanced GFP.
32 Tie2-Cre;N1ICD embryos that constitutively expressed N1ICD and EGFP in Tie2 þ hematovascular progenitor cells died at E11.0. 33 At E9.5 ( Figures 1a-d ), transgenic embryos were smaller than wild-type (WT) littermates and the YS was pale and lacked well-formed blood vessels (Figure 1b) . Similarly, although the dorsal aorta and the umbilical and vitelline arteries were preserved, the intraembryonic P-Sp/AGM area lacked hemoglobinized cells (Figure 1d ). In most Tie2-Cre;N1ICD embryos, the YS contained small, randomly located concentrations of hemoglobinized red blood cells (Figure 1b) . This phenotype suggested a severe alteration in embryonic angiogenesis associated with defects in primitive or definitive hematopoiesis. The phenotype worsened by E10.5 (Figures 1e-h ) and was
Figure 1 Constitutive Notch1 activation on Tie2
þ progenitor cells impairs hematopoietic development. WT and Tie2-Cre;N1ICD embryos (left and right panels, respectively) at E9.5 (a-d) and E10.5 (e-h), with the YS (a, b, e and f) and without it (c, d, g and h). (a, b) Morphology of the YS of WT and Tie2-Cre;N1ICD embryos. WT YS contains normally developed blood vessels (black arrow in a) that are absent in transgenic YS. Tie2-Cre;N1ICD YS is very pale, with hemoglobinized cells concentrated at one pole (white arrow in b). (c, d) Lateral views of WT and Tie2-Cre;N1ICD embryos. Black arrows indicate the P-Sp/AGM region with hemoglobinized content in WT, and the pale region in the transgenic embryo, indicative of defective definitive hematopoietic development. (e-h) At E10.5, defects in Tie2-Cre;N1ICD YS and embryos are more severe. Black arrows in (e) mark the well-developed WT YS blood vessels that are never seen in transgenic YS (f), which instead contains randomly located pockets of high hemoglobin content (white arrow). Lateral views of WT (g) and Tie2-Cre;N1ICD (h) embryos show the hemoglobinized dorsal aorta in the AGM region (black arrows) of a WT embryo that is absent in the transgenic embryo. Scale bars: 800 mm Notch regulates yolk sac hematopoietic progenitors I Cortegano et al accompanied by severe cardiac defects that presumably resulted in hemodynamic alterations, causing embryonic death.
33
CD31/PECAM1 was expressed on hematopoietic and endothelial cells in the P-Sp/AGM dorsal aorta and the YS vitelline artery (Supplementary Figure 1a-j) , indicating that early endothelial differentiation occurs in these vessels. Nevertheless, the arterial marker Efnb2 was ectopically expressed in venous endothelium ( Supplementary Figure 1k and l) while the venous marker Ephb4 was not expressed (Supplementary Figure 1m and n) . N1ICD staining labels arterial endothelium (Supplementary Figure 1o and Del Monte et al. 30 ), so the observation that Tie2-Cre-driven ectopic N1ICD expression promotes arterial differentiation of venous endothelium is consistent with the requirement of Notch in arterial endothelium differentiation. 34 LacZ staining of Tie2-Cre;R26R embryos (Supplementary Figure 1p) indicates that this driver is active throughout the endothelium and circulating cells and is an excellent tool for studying the effect of Notch overexpression in these tissues.
Histological analysis of embryos and YS revealed that, compared with the WT extraembryonic vasculature formed by the capillary plexus ( Figure 2a ) and vessels full of circulating cells (Figure 2c ), extraembryonic vessels in Tie2-Cre;N1ICD embryos were dilated and expanded (Figure 2b ). Moreover, transgenic embryos exhibited two types of blood islands: some with the lumen almost empty (Figure 2d ) and others full of cells (Figure 2b ). These presumably corresponded to the hemoglobinized YS pockets described above (Figures 1b and f) .
Confocal analysis of WT (Figure 2c 0 ) and transgenic YS showed that EGFP expression labeled most although not all circulating cells within the vessels, indicating that Tie2-Credriven ectopic N1ICD expression was not uniform (Figure 2d 0 ). At E9.5, the Tie2-Cre;N1ICD dorsal aorta was still a bilateral artery (Figure 2f ) indicating a delay in vascular development. Unlike in the WT situation, where hematopoietic cell clusters were observed budding from the ventral wall of the dorsal aorta (Figure 2e ), no clusters were detected in . (e, f) Transverse sections of E9.5 dorsal aorta at the P-Sp/AGM region level in WT (e) and Tie2-Cre;N1ICD embryos (f); transgenic animals have bilateral dorsal aortas (white arrows) and lack the hematopoietic cell clusters that start to bud off from the endothelium in WT embryos (black arrows in e). G, gut. (g, h) In situ hybridization of AML1/Runx1 in WT (g) and Tie2-Cre;N1ICD (h) vitelline artery. Hematopoietic cells almost obliterate the lumen of WT vitelline artery, whereas a single small hematopoietic cell cluster is seen in the Tie2-Cre;N1ICD vessel (black arrow in h). Figure 2a ). In the same embryos, the intraembryonic CD45 þ population was almost absent in the caudal region (which includes the P-Sp/AGM) (Figure 2i ). These data suggest that constitutive Notch1 expression in Tie2 þ cells leads to defects in YS hematopoietic and vascular development and to a blockade of intraembryonic definitive hematopoiesis similar to that described for Notch-deficient mice. 26, [35] [36] [37] N1ICD expression reduces the hematopoietic potential and favors the endothelial phenotype of Tie2 þ cells in the YS. Flow cytometry analysis of Tie2-Cre;N1ICD YS cells at E9.5 showed that just 40-60% of the recovered cells were EGFP þ , which may suggest incomplete Cre-mediated recombination and activation of the EGFP transgene (Figure 3a) . The number of EGFP þ and EGFP À cells recovered from YS of Tie2-Cre;N1ICD mice was lower than that recovered from WT mice (Figure 3b ; Supplementary  Figure 2b ). The co-expression of EGFP and N1ICD in Tie2-Cre;N1ICD mice 33 allowed us to examine the hematopoietic potential of FACS-purified total EGFP þ YS cell populations and of EGFP þ cells expressing the stem cell factor (SCF) receptor (c-Kit) at E9.5. After 7 days in methylcellulose cultures, the numbers of colonies derived from E9.5 EGFP þ cells, both total and c-Kit positive, was 10-to 20-fold lower than those derived from WT cells ( Figure 3c) ; however, numbers of primitive erythroid colonies were normal at E8.5 in total YS EGFP þ and WT cells (Supplementary Figure 2c) . In addition, whereas colonies growing from E9.5 WT and EGFP À cultures were BFU-E and CFU-M (Figure 3d , left panel and not shown), the small number of colonies detected in EGFP þ cultures contained elongated fibroblast-like cells surrounding central clusters of small round cells (Figure 3d , right panel). When EGFP þ colonies were transferred to fibronectin-coated plates, tube-like structures developed after 48 h that appeared to be pseudo-endothelial cords (Figure 3e ). These cells were positive for the endothelialspecific marker von Willebrand factor (vWF) (Figure 3f ). In agreement with these results, the CD31
À hemogenic endothelial cells 38 were significantly increased in EGFP þ cells from Tie2-Cre;N1ICD YS overexpressing Notch1 at E9.5 (Figures 3g and h ).
In the WT YS, two cell populations could be distinguished ex vivo according to the levels of c-Kit, c-Kit Notch regulates yolk sac hematopoietic progenitors I Cortegano et al as has been described. 15 However, EGFP þ Tie2-Cre;N1ICD cells displayed lower levels of TER119 than WT cells. Accordingly, the expression of both the fetal bH1 and the adult-type b1 hemoglobin was highly diminished in EGFP þ Tie2-Cre;N1ICD cells compared with WT cells (Figure 4f) . Finally, the quantification of the more immature c-Kit
À common erythro-myeloid progenitors 41 by 6-color cytometry showed that they were significantly increased in EGFP þ cells compared with WT cells (Figure 4g ). In summary, constitutive N1ICD expression on Tie2 þ cells blocks in the YS the maturation of erythroid precursors both of the primitive erythropoiesis wave and of the definitive transient erythro-myelopoiesis, resulting in an accumulation of erythro-myeloid progenitors and of immature proerythroblasts. The EGFP À erythroid cells present in Tie2-Cre;N1ICD YS had phenotypes similar to WT cells, although their total numbers were reduced ( Supplementary Figure 4a and b). The expression levels of adult-type b1 hemoglobin were strongly reduced, whereas the levels of fetal bH in EGFP À cells were lower compared with WT cells, this may be related with the smaller size of the EGFP À erythroid cell compartment (Figure 4f) .
Besides erythroid cells, the first hematopoietic-lineage cells generated in the YS belong to the megakaryocyte (MK) lineage. 15, 42 WT and Tie2-Cre;N1ICD YS did not differ in relative numbers of CD41 þ þ CD9 þ þ cells, which correspond to embryonic MKs (Figure 4h) . 42 Nevertheless, fewer total EGFP þ and EGFP (Figure 5d ), whereas the EGFP þ YS population contained elevated numbers of immature Mac1 þ cells. Mac1 þ þ cells in WT YS are mature myeloid cells, since they were negative for c-Kit, and expressed Gr1 and high levels of CD45 (Figures 5d and e) Figure 4d and 
e).
Notch1 activation on Tie2-derived YS cells dysregulates the transcriptional program that initiates hematopoietic differentiation. Analysis of FACS-purified EGFP
þ and WT YS cells by quantitative PCR (qPCR) revealed an association of N1ICD expression with substantial changes in expression of hematopoietic and vasculo/endothelial genes. EGFP þ cells expressed higher levels of Runx1 (Figure 5f ). The transcription factors SCL, Fli1 and Gata family members are implicated in the earliest stages of hematopoiesis/vasculogenesis in the mouse embryo, and have been proposed to form a gene regulatory network that operates during specification of vasculo-hematopoiesis. 44 EGFP þ cells expressed lower levels of Scl, Gata3 and Fli1 transcripts, whereas Gata1 and Gata2 were upregulated (Figure 5f ). The transcript levels of Pu1 and c-fms, which have a critical role in differentiation to myeloid lineages, 45 were increased in EGFP þ cells. In contrast, transcripts encoding myeloperoxidase and lysozyme, involved in differentiation of more mature myeloid stages, were strongly downregulated, in agreement with the incomplete myeloid development observed in EGFP þ Tie2-Cre;N1ICD cells. 43 Despite the marked alteration in erythropoiesis observed in Tie2-Cre;N1ICD embryos, the transcription of Klf1 and Klf2, important genes in this process 46 did not show variations. Constitutive Notch1 activation in Tie2-derived cells thus dysregulates the transcriptional program that initiates the first differentiation steps in early hematopoietic progenitor cells and some lineage-restricted precursors.
N1ICD expression in Tie2
þ cells induces high proliferation, cell-cycle activation and reduced apoptosis. Notch1 activation has been shown to enhance self-renewal, increases the stem-cell pool, alters differentiation processes and promotes cell-cycle progression. 24 The erythroid/myeloid differentiation arrest that we found at E9.5 in EGFP þ cells Notch regulates yolk sac hematopoietic progenitors I Cortegano et al derived from Tie2 þ N1ICD expressing progenitors was accompanied by an increase in the number of erythroid/ myeloid c-Kit þ immature cell progenitors. Also, FACSpurified EGFP þ Tie2-Cre;N1ICD cells cultured on OP9 grew at a 10-fold higher rate than WT or EGFP À Tie2-Cre;N1ICD cells (Figure 6a) . Analysis of the cell-cycle status of purified EGFP þ cells by propidium iodide (PI) staining revealed a higher number of cells in the S/G 2 M phases compared with WT cells (Figure 6b ). This was confirmed also for WT and Tie2-Cre;N1ICD cells by Hoechst staining of the nuclei of live cells, which allows ex vivo identification cell-cycle status, revealing a higher proportion of EGFP þ cells in S phase (Figure 6c ) than WT or EGFP À Tie2-Cre;N1ICD cells. In contrast, in vivo incorporation of the nucleotide analog EdU did not differ between EGFP þ and WT cells (Figure 6d) . To exclude the influence of gestational age differences between (Figure 6e ). These data thus indicate that N1ICD expression in Tie2 þ cells prevents apoptosis and induces a highly proliferative state in most YS hematopoietic progenitors, with an accumulation of cells in the S phase, which likely interferes with their differentiation.
Analysis of Notch pathway genes by qPCR revealed that Notch1, Hey2, Hes1, Jag1, Jag2, Dll1 and Dll4 were upregulated in EGFP þ cells relative to WT cells, consistent with an increase in Notch signaling activity (Figure 6f) . Interestingly, EGFP À Tie2-Cre;N1ICD cells showed equivalent levels to those from WT cells, except for Jag2, which was upregulated. Among the regulators of the cell-cycle machinery, both Cyclin-D1 and c-myb were induced in EGFP þ cells relative to WT cells, whereas the cell-cycle inhibitor p27 was downregulated. No significant changes were observed for c-myc, Id/Atp8b2 or p21 (Supplementary Figure 4f) .
Discussion
The aim of this study was to determine whether Notch function in embryonic hematopoiesis is restricted to the definitive hematopoietic compartment, as has been proposed based on loss-of-function approaches. 47 The Tie2 promoter is active in endothelial and hematopoietic lineages from E7.5 onwards, 48 and almost all primitive hematopoietic cells can be traced to Tie2 þ cells. N1ICD and Tie2 have a similar expression pattern in YS blood islands. 29, 30 As a strategy to induce Notch1 in embryonic hematopoietic cells we generated double transgenic embryos constitutively expressing N1ICD in Tie2 þ hematovascular progenitor cells. Our results show that constitutive N1ICD expression in Tie2 þ hematopoietic progenitors stimulates cellular proliferation at the expense of differentiation, disturbing the delicate balance between both processes and leading to a block of hematopoietic differentiation while promoting the accumulation of cells of intermediate phenotypes (Figure 7 ).
It is well established that Tie2 is required for primitive and definitive hematopoiesis. 49 We have observed that Tie2-Cre;N1ICD mice show around 50% of EGFP À cells, indicating that Tie2-Cre-driven recombination is, as previously reported, 50 incomplete. EGFP À cells express low fractions of Tie2, similarly to WT cells, and although in EGFP þ cells the expression of Notch1 and related genes is highly increased, in EGFP À cells it is close to that from WT, except for Jag2. Therefore, although we cannot completely exclude that some EGFP À cells derive from rare Tie2-independent hematopoietic cells, they are very likely the result of incomplete Cre recombination. Our data on EGFP À cells provide evidence of a non-cell autonomous effect of Notch1, probably acting through the Jag ligand. In fact, EGFP À cells have reduced numbers and seem to have altered c-Kit þ þ progenitor cells and differentiation in vitro. It seems that, in vivo, once the c-Kit þ þ cells overcome their differentiation block, they are able to proceed to normal primitive erythro-myelopoiesis (erythroid/MK differentiation, and
, although always maintaining reduced numbers of lineage-specific cells. Previous reports showed an essential role of Notch in the onset of definitive hematopoiesis in the mouse P-Sp/AGM region, but with little or no effect on the primitive hematopoietic wave. 26, [35] [36] [37] In contrast, our gain-of-function approach has not only allowed us to determine that adult-type P-Sp/AGM hematopoiesis is impaired in Tie2-Cre;N1ICD embryos, but also revealed severe alterations in YS-derived primitive and transient definitive hematopoiesis. At E9.5, the YS of transgenic embryos contains above-normal numbers of c-Kit-low expressing cells, and low numbers of immature c-Kit þ þ cells that have a weak hematopoietic potential in vitro. Constitutive Notch1 activation in Tie2 þ cells moreover leads to the maintenance in the YS of CD31
The in vivo mapping of Notch pathway activity in adult lymphoid tissues and in YS from E10.5 has being recently reported. 51 No Hes1 expression on embryo HSC was found, despite Notch1/2 expression, suggesting that Notch signaling was not activated. MKs and erythrocytes expressed active Notch2, whereas much higher Notch1 levels were found in endothelial CD31
þ precursors. The in vitro transduction of constitutive active truncated Notch2 in CD34 þ human cells showed increased numbers of basophilic immature erythroblast that did not reach mature stages. 52 A report using an N1ICD overexpression system in Tie2 þ cells similar to ours Figure 5f for each sample. *Po0.05, **Po0.01, ***Po0.001 also found, as we do, a block in erythroid cell development at the level of proerythroblasts, but quantification of the Ly6C þ myeloid cells led the authors to conclude that myeloid differentiation was preserved. 53 In our system, an extensive study of lineage markers and functional differentiation assays showed that N1ICD overexpression in Tie2 þ cells produces a defect in the maturation process of the erythroid, megakaryocytic and myeloid lineages that prevents them from reaching the last maturation stages, resulting in an accumulation of erythroid and myeloid cells at different stages of differentiation, including erythro-myeloid progenitors. A similar defect in the in vitro maturation of MKs has recently been described following activation of Dll4-Notch signaling in human cord blood CD34 þ cells. 54 In agreement with our Figure 7 Yolk sac hematopoiesis alterations in Tie2-Cre;N1ICD embryos. In the mouse at around embryonic day (E) 7.0-7.25 early hemangioblasts (HG) emerged from the posterior streak mesoderm and give rise to hemogenic endothelial cells (hEC), and angioblasts (AG) progenitor cells on the extraembryonic YS blood island. The AG will produce part of the YS vascular endothelial cells (EC). On the other hand, YS hematopoiesis occurs in two waves, the primitive (from BE7.25, yellow box) and definitive (green box) waves that overlap, temporally and spatially, and produce relatively short-lived cells. hEC give rise, first, to bipotential primitive megakaryocyte/erythroid progenitor (pMEP) that will in turn generate specific primitive progenitors for both cell lineages (pMK-CFC and EryP-CFC); and second, to primitive macrophage precursor cells (Mac-CFC). These progenitors will generate the primitive hematopoietic cell lineages: primitive erythrocytes (EryP), primitive megakaryocytes (pMK) -able to give rise to proplatelets -and primitive macrophages (pMF). This short-lived primitive wave is rapidly followed by the second hematopoietic wave that comprises YS definitive erythroid, megakaryocyte and several myeloid lineages. The YS definitive populations are believed to arise from transient multipotent progenitors (tMPPs) -but not from hematopoietic stem cells, which emerge in the mouse YS at around E9.0 -that are detected from BE8.25 and generate different transient cell populations of restricted erythro-myeloid progenitors (EMPs). EMPs comprise definitive-type bipotential megakaryocyte/erythroid progenitor (dMEP) that will give rise to transient definitive megakaryocyte and erythrocyte progenitors (dMK-CFC and BFU-E) and definitive myeloid progenitors (Mye-CFC), from which definitive-type erythrocytes (EryD), megakaryocytes (dMK) -with the capacity to originate proplatelets -and several myeloid lineages: macrophages (MF), granulocytes and mast cells will be produced. The expression of N1ICD in early Tie2 þ progenitors produces severe alterations in both YS À primitive and definitive hematopoiesis characterized by high frequency of c-Kit-expressing multipotential and lineage-restricted progenitors (encircled by the orange bubbles) at E9.5, whereas it blocks the generation of the last maturation stages of erythrocytes, megakaryocytes and myeloid lineages. First, no CD71 55 Our data additionally show that expression of N1ICD in Tie2 þ cells prevents apoptosis and disrupts the proliferation and differentiation balance of embryonic hematopoietic cell lineages. Since the equilibrium between cellular proliferation and differentiation is strictly regulated, 56 any alteration will affect lineage development. Our results suggest that Notch1 may normally function to fine-tune this process. Thus in transgenic YS, lineage-restricted progenitors (erythroblasts, megakaryoblasts and myeloblasts) would be unable to differentiate because of a continued proliferative stimulus elicited by constitutive N1ICD activity. This results in low numbers of HSCs and the accumulation of different intermediate progenitors, while impeding terminal differentiation of endothelial, erythroid, MK and myeloid cells. This phenotype would be compatible with a stem-cell exhaustion process that would occur early during primitive hematopoiesis. 56 In conclusion, our results show an unrevealed role of Notch signaling in YS-derived hematopoiesis by interfering in the proliferation and differentiation processes of lineagerestricted intermediate progenitors, producing a block of terminal differentiation.
Materials and Methods
Transgenic mice, embryo dissection and cell suspensions. Embryos overexpressing N1ICD-EGFP in Tie2-derived cells (Tie2-Cre;N1ICD) and their WT littermates were obtained by crossing Rosa26-N1ICD-EGFP 32 (for simplicity N1ICD) with Tie2-Cre transgenic mice. 31 Mice were maintained in the animal facility of the Centro Nacional de Investigaciones Cardiovasculares under pathogen-free conditions. All animal procedures conformed to EU Directive 2010/ 63EU and Recommendation 2007/526/EC regarding the protection of animals used for experimental and other scientific purposes, enforced in Spanish law under Real Decreto 1201/2005. Embryos were dissected and exsanguinated, and the embryonic blood and tissues (YS and the caudal portion of the embryo containing the P-Sp/AGM region) were recovered as described. 57 Cell suspensions were prepared from pooled embryonic tissues of the same gestational age by mechanical dissociation and cells were counted in a Neubauer chamber.
Flow cytometry analysis and cell sorting. The monoclonal antibodies (mAbs) used are detailed in Table 1 . Cell suspensions were incubated with blocking solution (Fc block; BD Biosciences Inc., San José, CA, USA) for 10 min at 41C. After washing, the cells were incubated with biotinylated, PE-, allophycocyanin-, PerCP-cyanin5.5 or PE-cyanin7-conjugated mAbs. Biotinylated mAbs were revealed by PE, allophycocyanin or PE-cyanin7-streptavidin. Cell debris and dead cells were discarded by 4 0 ,6-diamidino-2-phenylindole (DAPI) exclusion after gating for forward scatter (FSC) versus side scatter (SSC). EGFP detection allowed the identification and purification of N1ICD-overexpressing EGFP þ cells. Specific mAb signals were defined against the background of irrelevant, isotypematched mAbs. Experiments were performed in a FACSCalibur flow cytometer (BD Biosciences) and analyzed with the FlowJo-v6.3.4 software package (Tree Star Inc., Ashland, OR, USA). Stained cells were purified by FACS, using a FACSAria cell sorter (BD Biosciences) under sterile conditions. The purity of the recovered cells was above 98%.
In situ hybridization, hematoxylin-eosin, May Grü mwaldGiemsa and immunofluorescence staining. Embryos were dissected and fixed with 4% paraformaldehyde in phosphate-buffered saline overnight at 4 1C. Tissue embedding in paraffin, histological sectioning and hematoxylin and eosin staining were performed following standard protocols. In situ hybridization was carried out as described. 58 Cytospin preparations of cell suspensions (2.0-2.5 Â 10 4 ) were dried at room temperature and fixed in 100% methanol, before being stained with May Grümwald-Giemsa solution (Materlab S.L., Madrid, Spain). vWF immunostainings were performed on slides of cell suspensions recovered from MethoCult cultures, as described. 57 Confocal analysis. E9.5 WT and Tie2-Cre; N1ICD YSs were fixed 3 h in PFA 4%. Nuclei were stained with DAPI 1 : 1000 (124653; Merck, Readington, NJ, USA) for 15' before microscopy scanning. YSs were scanned for EGFP expression with a Leica SPE confocal microscope (Leica Microsystems, Solms, Germany) and LasAF software (Leica Microsystems).
Clonal assays for progenitor identification. Purified EGFP þ or WT YS cells (0.3-3.0 Â 10 3 /50 ml) in DMEM (Lonza, Verviers, Belgium) were seeded in MethoCult M3434 methylcelullose medium (StemCell Technologies Inc., Vancouver, BC, Canada) and plated in triplicate in 48-well plates (Nunc, Thermo-Scientific, Roskilde, Denmark). Plates were kept at 371C and 5% CO 2 for 7-10 days, and CFUs were counted by two independent observers under light microscopy (Leica-DFC 320 microscope, Leica Microsystems). Cell suspensions of the EGFP þ CFUs were transferred to fibronectin-coated plates (BD Biosciences) and supplemented with the pro-endothelial factors basic fibroblast growth factor and vascular endothelial growth factor (Peprotech, London, UK), or used for cytospin preparations. For MK progenitor quantification (MK-CFU), viable CD41 þ þ cells were plated in IMDM (Lonza) at 0.1-3.0 Â 10 3 in MegaCult-C medium (StemCell Technologies Inc.), in 2-well chamber slides and incubated at 371C for 7-10 days. Slides were dried before staining with acetylthiocholiniodide (SigmaAldrich, St. Louis, MO, USA) as indicated by the manufacturer.
Proliferation, cell cycle and apoptosis analysis. Total YS cells were cultured over OP9 stromal cells pretreated with mytomycin (Sigma-Aldrich) in IMDM supplemented with IL7 (Peprotech), IL3 (Stem Cell), SCF (Peprotech), FLT3 ligand (Peprotech) and GM-CSF (Peprotech). Cells were seeded in 96-well plates (Nunc, Rochester, NY, USA) and cultured for 7 days. The cells were recovered, counted and analyzed by FACS to quantify EGFP þ cells. Aliquots of these cells were reseeded at 2 Â 10 3 /well and recovered after 7 days. For cellcycle analysis, FACS-purified EGFP þ or WT cells (10 5 ) were fixed in pre-cooled 70% ethanol, treated with RNAse, stained for DNA with PI, and analyzed in a FACSCalibur flow cytometer (BD Biosciences). In other experiments, 10 5 cells from WT or Tie2-Cre;N1ICD YS were incubated with Hoechst 33342 (5 mg/ml; Invitrogen, Carlsbad, CA, USA) and verapamil (20 mM; Sigma-Aldrich) in IMDM at 371C in the dark, and analyzed in a FACSVantage flow cytometer (BD Biosciences). Samples from adult thymus and a cell line were used as controls (data not shown). For in vivo S-phase cell analysis, pregnant females were intraperitoneally injected with 10 mM (100 ml) 5-ethinyl-2'-deoxyuridine (EdU; Invitrogen), and EGFP þ or WT cells were FACS purified. EdU incorporation was measured with the Click-iT EdU Flow Cytometry Kit (Invitrogen). Apoptotic cells were detected by flow cytometry using the 7-AAD Apoptosis Detection kit (Immunostep, Salamanca, Spain). 
